| Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells S Masuda, M Nagao, K Takahata, Y Konishi, F Gallyas Jr, T Tabira, ... Journal of Biological Chemistry 268 (15), 11208-11216, 1993 | 547 | 1993 |
| Direct effect of Taxol on free radical formation and mitochondrial permeability transition G Varbiro, B Veres, F Gallyas Jr, B Sumegi Free Radical Biology and Medicine 31 (4), 548-558, 2001 | 296 | 2001 |
| Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ... Critical care medicine 30 (5), 1071-1082, 2002 | 251 | 2002 |
| Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase-1 inhibition in oxidative stress A Tapodi, B Debreceni, K Hanto, Z Bognar, I Wittmann, F Gallyas Jr, ... Journal of Biological Chemistry 280 (42), 35767-35775, 2005 | 209 | 2005 |
| Antioxidant and anti-inflammatory effects in RAW264. 7 macrophages of malvidin, a major red wine polyphenol E Bognar, Z Sarszegi, A Szabo, B Debreceni, N Kalman, Z Tucsek, ... PloS one 8 (6), e65355, 2013 | 179 | 2013 |
| Regulation of kinase cascades and transcription factors by a poly (ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice B Veres, B Radnai, F Gallyas Jr, G Varbiro, Z Berente, E Osz, B Sumegi The journal of pharmacology and experimental therapeutics 310 (1), 247-255, 2004 | 165 | 2004 |
| Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock B Veres, F Gallyas Jr, G Varbiro, Z Berente, E Osz, G Szekeres, C Szabo, ... Biochemical pharmacology 65 (8), 1373-1382, 2003 | 157 | 2003 |
| Inhibiting poly (ADP-ribose) polymerase: a potential therapy against oligodendrocyte death S Veto, P Acs, J Bauer, H Lassmann, Z Berente, G Setalo Jr, G Borgulya, ... Brain 133 (3), 822-834, 2010 | 119 | 2010 |
| BGP-15—a novel poly (ADP-ribose) polymerase inhibitor—protects against nephrotoxicity of cisplatin without compromising its antitumor activity I Racz, K Tory, F Gallyas Jr, Z Berente, E Osz, L Jaszlits, S Bernath, ... Biochemical pharmacology 63 (6), 1099-1111, 2002 | 109 | 2002 |
| Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in the central nervous system T Tabira, Y Konishi, Gallyas, Ferenc Jr International Journal of Developmental Neuroscience 13, 241-252, 1995 | 107 | 1995 |
| PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway E Hocsak, V Szabo, N Kalman, C Antus, A Cseh, K Sumegi, K Eros, ... Free Radical Biology and Medicine 108, 770-784, 2017 | 106 | 2017 |
| Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis B Gasz, B Racz, E Rőth, B Borsiczky, A Ferencz, A Tamas, B Cserepes, ... Peptides 27 (1), 87-94, 2006 | 103 | 2006 |
| TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol PB Jakus, N Kalman, C Antus, B Radnai, Z Tucsek, F Gallyas Jr, ... The Journal of nutritional biochemistry 24 (5), 819-823, 2013 | 101 | 2013 |
| Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects T Atlasz, K Szabadfi, P Kiss, B Racz, F Gallyas, A Tamas, V Gaal, ... Annals of the New York Academy of Sciences 1200 (1), 128-139, 2010 | 99 | 2010 |
| Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis B Racz, B Gasz, B Borsiczky, F Gallyas Jr, A Tamas, R Jozsa, A Lubics, ... General and comparative endocrinology 153 (1-3), 115-123, 2007 | 93 | 2007 |
| The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways B Rácz, F Gallyas Jr, P Kiss, G Tóth, O Hegyi, B Gasz, B Borsiczky, ... Regulatory peptides 137 (1-2), 20-26, 2006 | 93 | 2006 |
| Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases A Szabo, K Sumegi, K Fekete, E Hocsak, B Debreceni, G Setalo Jr, ... Biochemical pharmacology 150, 86-96, 2018 | 90 | 2018 |
| PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3β pathway A Palfi, A Toth, K Hanto, P Deres, E Szabados, Z Szereday, G Kulcsar, ... Journal of molecular and cellular cardiology 41 (1), 149-159, 2006 | 84 | 2006 |
| Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation B Racz, K Hanto, A Tapodi, I Solti, N Kalman, P Jakus, K Kovacs, ... Free Radical Biology and Medicine 49 (12), 1978-1988, 2010 | 82 | 2010 |
| Preventing apoptotic cell death by a novel small heat shock protein S Bellyei, A Szigeti, E Pozsgai, A Boronkai, E Gomori, E Hocsak, R Farkas, ... European journal of cell biology 86 (3), 161-171, 2007 | 80 | 2007 |
Prof. Balázs SÜMEGI; DSCProfessor of Biochemistry; University of Pecs; Medical SchoolE-mailová adresa ověřena na: aok.pte.hu
